Steroids for Chronic Inflammatory Demyelinating Polyneuropathy
Abstract
The efficacy and safety of high-dose, intermittent IV methylprednisolone (IVMP) as initial and long-term maintenance therapy for chronic inflammatory demyelinating polyneuropathy (CIDP) were analyzed by a retrospective review of outcome data derived from patients’ medical records between 1992 and 2003 at Washington University School of Medicine, St Louis, MO.
DOI: https://doi.org/10.15844/pedneurbriefs-19-3-3 | Journal eISSN: 2166-6482
Language: English
Page range: 19 - 19
Published on: Mar 1, 2005
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
© 2005 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.